ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 617

$586K Total Retail Price of All Prescriptions

Rank: 55 out of 617

502 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,591 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 480 420 1 2
LISINOPRIL 446 390 2 5
LEVOTHYROXINE SODIUM 431 361 3 1
OMEPRAZOLE 366 307 4 3
AMLODIPINE BESYLATE 315 305 5 6
ATORVASTATIN CALCIUM 260 241 6 14
GABAPENTIN 240 219 7 16
WARFARIN SODIUM 231 209 8 7
SERTRALINE HCL 223 176 9 20
LOSARTAN POTASSIUM 221 211 10 22
FUROSEMIDE 198 198 11 4
POTASSIUM CHLORIDE 173 154 12 10
METFORMIN HCL 172 107 13 9
METOPROLOL TARTRATE 168 161 14 11
POLYETHYLENE GLYCOL 3350 151 140 15 32
HYDROCHLOROTHIAZIDE 151 151 15 13
GLIMEPIRIDE 148 144 17 33
CARVEDILOL 138 133 18 19
FENOFIBRATE 137 94 19 58
NAMENDA 135 135 20 35
HYDROCODONE-ACETAMINOPHEN 129 123 S3 21 8
TRAMADOL HCL 127 123 22 15
DONEPEZIL HCL 120 120 23 30
ALLOPURINOL 109 96 24 27
ATENOLOL 108 108 25 17
CLONIDINE HCL 107 95 26 55
ZOLPIDEM TARTRATE 97 91 27 23
METOPROLOL SUCCINATE 91 79 28 12
CYMBALTA 89 85 29 49
LOVASTATIN 87 71 30 57
ENALAPRIL MALEATE 84 82 31 34
INDAPAMIDE 82 72 32 231
ALENDRONATE SODIUM 81 79 33 25
SPIRONOLACTONE 78 78 34 42
TAMSULOSIN HCL 75 73 35 26
LANTUS 72 55 36 39
PRAVASTATIN SODIUM 70 58 37 21
DOXAZOSIN MESYLATE 69 67 38 79
BISOPROLOL FUMARATE 65 56 39 100
TRAZODONE HCL 63 39 40 51
TRIAMCINOLONE ACETONIDE 63 55 40 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 63 40 29
MIRTAZAPINE 62 62 43 50
LOSARTAN-HYDROCHLOROTHIAZIDE 61 57 44 46
FLUOXETINE HCL 61 55 44 73
BACLOFEN 59 38 46 146
CHOLESTYRAMINE 56 56 47 302
SPIRIVA 55 54 48 61
DIOVAN 54 52 49 41
CRESTOR 53 53 50 28
LANTUS SOLOSTAR 51 46 51 115
PAROXETINE HCL 51 51 51 62
CARBIDOPA-LEVODOPA 50 43 53 69
OXYBUTYNIN CHLORIDE 50 30 53 88
AMITRIPTYLINE HCL 50 43 R 53 56
FLUTICASONE PROPIONATE 50 49 53 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.